v3.26.1
Share-based compensation plan - Restricted shares plan (Details)
6 Months Ended 12 Months Ended
Jun. 30, 2026
BRL (R$)
shares
shares
Dec. 31, 2025
BRL (R$)
shares
Dec. 31, 2024
BRL (R$)
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Non-current provisions for employee benefits | R$ R$ 304,921,000 R$ 332,322,000  
Restricted share units      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Number of other equity instruments outstanding in share-based payment arrangement 3,092,957 3,076,116  
Shares granted 532,774    
Restricted stock, year one 440,715    
Restricted stock, year two 235,794    
Restricted stock, year three 1,982,244    
Restricted stock, year four 241,637    
Restricted stock, year five 192,567    
Non-current provisions for employee benefits | R$ R$ 76,870,000 R$ 80,742,000 R$ 60,226,000
Increase Provision Share Based Payment | R$ 23,159,000 45,642,000  
Decrease Provision Share Based Payment | R$ (27,031,000) R$ (25,126,000)  
Grant Year 2023 | Restricted share units      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Fair value on grant date | R$ R$ 50.51    
Number of other equity instruments outstanding in share-based payment arrangement 277,249  
Shares granted 6,033    
Grant Year 2024 | Restricted share units      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Fair value on grant date | R$ R$ 56.09    
Number of other equity instruments outstanding in share-based payment arrangement 2,149,682 2,331,602  
Shares granted 50,731    
Restricted stock, year one 440,715    
Restricted stock, year three 1,708,967    
Grant Year 2025 | Restricted share units      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Fair value on grant date | R$ R$ 60.47    
Number of other equity instruments outstanding in share-based payment arrangement 477,431 467,265  
Shares granted 10,166    
Restricted stock, year two 235,794    
Restricted stock, year four 241,637